By Amy Norton
WEDNESDAY, Feb. 26, 2020 (HealthDay Information) — The immunotherapy drug Keytruda may well present a new treatment possibility to women with an aggressive variety of breast most cancers, a clinical trial indicates.
The study uncovered that for women with “triple-destructive” breast most cancers, including Keytruda to regular chemotherapy enhanced their odds of responding.
And in the months afterward, women treated with the drug ended up significantly less very likely to see their most cancers arrive again.
The findings are encouraging in a disease that is hard